This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.
Otherwise, enjoy the column!
Subscribe to The Market Chronicle to get the Daily Monster Market Commentary and join the 2,893 subscribers getting it for FREE!
July 16 – Stock mentions: SPY, XBI, HGX, QCOM, ROKU, JD, AMD, NVDA
Stocks Fall on July 16
Stocks fell some on July 16, but I really don’t expect it to last. However, I noted a word of caution in the paragraph below. If hadn’t been some negative comment from President Trump about the China trade, we probably would have had a flat day.
I think at this point if the trade war probabilities have been fully baked into the market at this point, then I don’t know what to say. After a year of this non-sense, judging from today’s reaction, the market is over the trade war. I know I am. I talked about more in a video today: 2 Rate Cuts In July Back On The Table?
S&P 500 (SPY)
The S&P 500 stalled some on July 16, falling by about 35 basis points. The index managed to hold on to support at 3,000, which is good a start. As a reader pointed out to me last night, it looked as if the index is forming a rising wedge. While I can’t say I haven’t been tracking the same thing the last few days, I have been hesitant to call it, because I am seeing a different variation of it forming across differing indexes. However, I decided we should draw it, and make it official and see how it develops. This has been the one short-term wrinkle in my other bullish assessment.
Should the index fall, it is likely to drop to around 2,940. At this point I’m not ready to give a signal that shall, I will know better tomorrow, July 17.
I’m continuing to watch the HGX housing index, as it is once again flirting with a break out at 325. Still, this has been a powerful leading indicator to the S&P 500 in the past. There is a clear uptrend in this index. This is one reason why I am hesitant about the S&P 500 falling, as noted above.
The biotech XBI ETF has been holding support at $85.25, I just wonder for how much longer. The uptrend is has broken as the ETF has traded sideways through it. Not a great sign. A break below $85.25 sends the XBI down to $82.90.
Subscribe to the The Market Chronicle to get it Daily and join the 2,893 subscribers getting it for FREE!
Qualcomm is rising in the after-hours after the DOJ has requested to pause its antitrust lawsuit. It looks the stock could rise to around $83.
Roku now has a valuation of almost $13 billion, and it is currently trading at a valuation that is 40% higher than Netflix, with a one-year forward price to sale ratio of 9, versus Netflix at 6.4. If you want to pay that valuation be my guest. My best guess at this point is that ROKU rise to around $120, I guess you can’t stop the momentum.
JD.com is not working out the way I anticipated. The stock has stalled out at resistance at $31.50, and it is now testing the uptrend. A break below $29.90 will cause me to re-evaluate my thinking.
AMD fell some today, but the uptrend remains in place, therefore the march to $36.15.
Meanwhile, NVDA continues to stay within a trading range moving higher. I still think NVDA goes to $178.
That’s going to be all for tonight, until tomorrow.
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.